Metoclopramide Accord-Uk (Metoclopramide Hydrochloride)

Metoclopramide works by blocking dopamine D2 receptors in the chemoreceptor trigger zone, which reduces the stimulus for nausea. It also stimulates acetylcholine release in the gastrointestinal tract, promoting faster gastric emptying and strengthening the lower esophageal sphincter, while modestly antagonising 5‑HT3 receptors.

The appropriate dose of Metoclopramide Accord-Uk is determined by the prescribing healthcare professional based on the patient’s condition, age, renal function and other clinical factors. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for Metoclopramide in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoclopramide differs from many antiemetics by combining dopamine antagonism with pro‑kinetic activity, which can be advantageous for patients with delayed gastric emptying. Other classes, such as 5‑HT3 antagonists, focus solely on nausea pathways and lack the gastrointestinal motility benefits.

Metoclopramide Accord-Uk should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain its stability.

The medication is taken orally, usually with or without food, as directed by the prescriber. Patients should swallow the tablet whole with a glass of water and follow any specific timing instructions provided by their healthcare professional.

Serious risks include the development of tardive dyskinesia, a potentially irreversible movement disorder, neuroleptic malignant syndrome, severe allergic reactions such as anaphylaxis, and significant depression or suicidal thoughts. Prompt medical attention is required if any of these occur.

Metoclopramide should be avoided in patients with known hypersensitivity to the drug, those with a history of extrapyramidal disorders, severe renal impairment without dose adjustment, and individuals taking interacting medications that are contraindicated. A healthcare professional should assess suitability before prescribing.